Biotechnology

https://techpapersworld.com/wp-content/uploads/2024/07/Menarinis-cell-based-non-1280x720.jpg

BiotechnologyMenarini’s cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw

The Reproductive Precision Medicine Unit of Menarini Silicon Biosystems (MSB) presented last week, at the 21st World Congress of the Fetal Medicine Foundation meeting in Lisbon, Portugal, results of a large multicenter study describing their next generation non-invasive prenatal testing technology using fetal cells isolated from maternal blood. The genomic analysis of these fetal cells showed a high concordance with the analysis of fetal cells obtained from invasive diagnostic procedures. Moreover, MSB’s cell-based test, under development, demonstrated its potential...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2022/09/Chi-Biotech-Launches-Free-To-Use-Next-Gen-1280x720.jpg

BiotechnologyKanazawa University research: Sensing a biomarker

Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Biosensors and Bioelectronics: X a novel approach for detecting a particular biomolecule associated with several diseases. The results show good sensitivity and selectivity, and may lead to the development of a low-cost, rapid detection device useful in cancer prognosis. Human diseases are often the result of DNA transcriptions gone wrong. Transcription refers to the copying of parts of a DNA molecule — the ‘genetic code’ — into an...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/05/Wolfer-Finance-Launches-1280x720.jpg

BiotechnologyWolfer Finance Launches a Token Sale on Akemona for a Greener Bitcoin

Akemona, a leading funding portal and asset tokenization platform, announces the Wolfer Finance Corporation token sale launch on the Akemona portal. For more information about the Wolfer Finance offering, please visit https://akemona.com/offerings/wolfer. The offering is open to the public. Wolfer Finance Corporation, established in 2022, is selling shares represented by digital security tokens to raise funds for capital investment. These funds will support the expansion of current business operations and diversification into new ventures. The tokens represent ownership in Wolfer...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/05/GenScript-Biotech-Corporation-1280x720.jpg

BiotechnologyGenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications

GenScript Biotech Corporation, a global leader in life science research tools and services, has today announced the expansion of its in vitro transcription (IVT) RNA synthesis portfolio to include self-amplifying RNA (saRNA). This cutting-edge addition reinforces GenScript’s position at the forefront of IVT RNA technology, offering a new and novel format for researchers working in applications such as vaccine, cancer immunotherapy, and gene or cell therapy development. Self-amplifying RNA is a revolutionary RNA platform that can amplify...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/04/Bitech-Technologies-and-1280x720.jpg

BiotechnologyBitech Technologies and Bridgelink Merge to Conquer U.S. Battery Energy Storage and Solar Markets, Prepare to Uplist on NASDAQ

Bitech Technologies Corporation [OTCQB: BTTC], (“the Company” or “Bitech”), a technology solution provider dedicated to green energy solutions, is pleased to announce that it has completed the previously announced acquisition of Emergen Energy LLC (“Emergen”) on April 24, 2024. Emergen was a wholly owned subsidiary of Texas-based Bridgelink Development, LLC (“Bridgelink”), a tier 1 solar and energy storage project development company, to control a pipeline of approximately 5.8 GW (gigawatts) of power in several battery energy storage system (BESS)...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/04/IdeeLab-Joins-the-Ginkgo-1280x720.jpg

BiotechnologyIdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service

IdeeLab Biotechnology, a Brazilian company aiming to develop innovations and biological solutions for agriculture, today announced that is has entered into an agreement with Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, to join the Ginkgo Technology Network. The Ginkgo Technology Network is a groundbreaking global ecosystem of cutting-edge technology partners dedicated to driving innovation in customer R&D programs. Ginkgo plans to integrate the technological capabilities of its network partners...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/03/PROTEONIC-UNVEILS-EARLY-1280x720.jpg

BiotechnologyPROTEONIC UNVEILS EARLY ACCESS PROGRAM, ELEVATING VIRAL VECTOR TITERS WITH TRANSFORMATIVE LV-2G UNIC® TECHNOLOGY

ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, is announcing the launch of its highly anticipated LV-2G UNic® Early Access Program. This program marks a significant milestone in lentivirus manufacturing optimization, offering access to groundbreaking vector technology designed to revolutionize viral vector production. With the official launch on March 20, 2024, ProteoNic extends a warm invitation to CDMOs, biotechs, and biopharmaceutical companies to experience firsthand the transformative potential of...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/03/Cure51-raises-a-E15-million-1280x720.jpg

BiotechnologyCure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

Cure51, a Techbio company seeking to unlock the biological mechanisms responsible for exceptional survivors among cancer patients, today announced that it has successfully raised €15 million in a seed funding round led by Sofinnova Partners. Other investors included: Hitachi Ventures GmbH, Life Extension Ventures, Xavier Niel, and Olivier Pomel, CEO, and co-founder of Datadog. The funding received will enable Cure51 to build a unique cohort, exploring the molecular processes by which certain cancer patients survive for very...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/03/Leading-Edge-Technologies-1280x720.jpg

BiotechnologyLeading-Edge Technologies, Data and Insights: Bio-IT World Conference & Expo Highlights the Drivers of Precision Medicine Innovation

Life science innovation doesn’t happen in a vacuum. It results from leaders with complementary expertise partnering across organizations and countries to build on data, research, and case studies—all facilitated by leading-edge technologies. From April 15-17, more than 3,000 pharmaceutical, biotechnology and IT leaders will gather for the 23rd annual Bio-IT World Conference & Expo in Boston to put this model into action. They will discuss the new AI and machine learning, digital twins, multiomics, quantum computing, high-performance computing, bioinformatics, and data...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2022/09/CellOrigin-Biotech-Announces-Global-Strategic-1280x720.jpg

BiotechnologyNew Season of I am BIO Podcast to Showcase Life-Changing Biotech Breakthroughs

On February 27, the Biotechnology Innovation Organization (BIO) premiers its Spring season of the I am BIO podcast with a discussion of new options for sickle cell patients. A groundbreaking treatment using CRISPR technology provides new hope for the nearly 100,000 Americans living with sickle cell disease – a disease and community that has been neglected for decades. “The recent FDA gene-therapy approvals reflect breathtaking progress, not only for sickle cell patients, but also the biotech industry,” said...

Older Posts